Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Schouten

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
STEP Perspective|January 1, 1995
Protease inhibitorsJ T Schouten
Research Initiative, Treatment Action : RITA|September 11, 2001
The case against a when-to-start antiretroviral therapy trialJ T Schouten
Hawaii Medical Journal|July 1, 1990
Life Foundation respondsJ T Schouten
STEP Perspective|January 1, 1997
HIV drug resistance and the other causes of treatment failureJ T Schouten
STEP Perspective|January 1, 1995
Oral ganciclovirJ T Schouten
STEP Perspective|May 22, 2001
Medical marijuana: legal considerationsJ T Schouten
STEP Perspective|April 1, 1996
FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug AdministrationJ T Schouten
Research Initiative, Treatment Action : RITA|May 22, 2001
After the drugs: what's next?J T Schouten
STEP Perspective|May 22, 2001
Controlling HIVJ T Schouten
JAMA|November 18, 1983
Tumor implantation in a skin flapJ T Schouten
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
STEP Perspective|January 1, 1995
Protease inhibitorsJ T Schouten
Research Initiative, Treatment Action : RITA|September 11, 2001
The case against a when-to-start antiretroviral therapy trialJ T Schouten
Hawaii Medical Journal|July 1, 1990
Life Foundation respondsJ T Schouten
STEP Perspective|January 1, 1997
HIV drug resistance and the other causes of treatment failureJ T Schouten
STEP Perspective|January 1, 1995
Oral ganciclovirJ T Schouten
STEP Perspective|May 22, 2001
Medical marijuana: legal considerationsJ T Schouten
STEP Perspective|April 1, 1996
FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug AdministrationJ T Schouten
Research Initiative, Treatment Action : RITA|May 22, 2001
After the drugs: what's next?J T Schouten
STEP Perspective|May 22, 2001
Controlling HIVJ T Schouten
JAMA|November 18, 1983
Tumor implantation in a skin flapJ T Schouten
Pageof 3